Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01459458 · ClinicalTrials.gov registry record · Phase 3

Family Planning-based Partner Abuse Intervention to Reduce Unintended Pregnancy

A Phase 3 study, sponsored by University of Pittsburgh.

Completed
Registry status
Phase 3
Development phase
3,687
Enrollment target

NCT01459458: Completed Phase 3 study, sponsored by University of Pittsburgh.

NCT01459458 is a Phase 3 study that has completed, run by University of Pittsburgh. The registered enrollment target is 3,687 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (378% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01459458, a Phase 3 study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
Phase 3
Development phase
3,687 participants
Enrollment target

Study Summary

This is a community-based participatory study to test a brief intervention to reduce risk for intimate partner violence (IPV) and associated unintended pregnancy among young, medically underserved women attending family planning (FP) clinics. Women ages 16-29 years utilizing FP clinics report higher rates of IPV compared to their same-age peers, experiences associated with unintended pregnancy. A critical mechanism connecting IPV with poor reproductive health is abusive partners' control of women's reproduction through condom refusal, pressuring women to get pregnant, and birth control sabotage, a phenomenon described as reproductive coercion. In the investigative team's pilot intervention study 53% of young women using FP clinics reported ever experiencing IPV, and 25% reported reproductive coercion, the combination of which was strongly associated with unintended pregnancy. The proposed reproductive coercion/partner violence intervention was developed collaboratively by community-based practitioners, advocates, and researchers, with significant input from FP clients. Designed to be implemented within routine FP care, maximizing feasibility and sustainability of this program, the intervention provides 1) client education and assessment regarding IPV and reproductive coercion; 2) discussion of harm reduction behaviors to reduce risk for unintended pregnancy and IPV victimization, and 3) supported referrals to IPV victim services. This is a full-scale RCT to assess the effects of this innovative program on IPV, reproductive coercion and unintended pregnancy, major health threats for medically underserved women. Evaluation of this intervention will involve random assignment of 25 FP clinics (unit of randomization) in Western PA to either intervention or control (i.e., standard-of-care) conditions. Female FP clients ages 16-29 (N=3600) will be assessed at baseline, 12-20 weeks (FU1), and 12 months (FU2) to assess intervention effects on knowledge and behaviors related

Primary Outcome

baseline-adjusted differences in post-intervention partner violence victimization up to 12 months {pooled analysis of FU 1 (12-20 weeks) and FU 2 (12 month) score}

Interventions

  • BEHAVIORAL Family Planning-based Partner Violence Intervention

Trial Details

FieldValue
Enrollment Target 3,687 participants
Start Date 2011-10
Est. Completion 2015-09
Phase Phase 3
University of Pittsburgh

1,238 total trials

What the finished NCT01459458 record still lists

NCT01459458 is an interventional study that assigns participants to a tested intervention. Its 3,687 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (378% higher).

The record links to 0 conditions, and to 1 intervention - of which Family Planning-based Partner Violence Intervention is the first listed.

NCT01459458 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01459458 about?

NCT01459458 is a clinical study titled "Family Planning-based Partner Abuse Intervention to Reduce Unintended Pregnancy". This is a community-based participatory study to test a brief intervention to reduce risk for intimate partner violence (IPV) and associated unintended pregnancy among young, medically underserved women attending family planning (FP) clinics. Women ages 16-29 years utilizing FP clinics report higher...

What is the current status of trial NCT01459458?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,687 participants. The study started on 2011-10. Estimated completion is 2015-09.

What interventions are being tested in trial NCT01459458?

The interventions under investigation include: Family Planning-based Partner Violence Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01459458?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01459458's enrollment target sits among peer trials

3,687 66th of 2000 higher than 1,935 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06784960 · 3,689 participants · NA

    Communication Strategies to Increase HPV Vaccination Intention

  • NCT06401863 · 3,691 participants · NA

    Shared Decision for Drug Interactions in Oral Anticoagulation

  • NCT06058377 · 3,680 participants · Phase 3

    Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

  • NCT06076304 · 3,720 participants · Phase 4

    Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01459458, the US trial registry maintained by the National Library of Medicine. NCT01459458 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.